atenolol has been researched along with Hyperthyroid in 24 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetics of atenolol and the effect of the drug on the clinical and laboratory features of hyperthyroidism were studied in 23 patients with hyperthyroidism." | 9.06 | Pharmacokinetics and clinical effects of atenolol in therapy of hyperthyroidism. ( Geffner, DL; Hershman, JM; Sladek, J, 1990) |
| "1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it with propranolol." | 9.04 | Comparative trial of atenolol and propranolol in hyperthyroidism. ( McDevitt, DG; Nelson, JK, 1978) |
| "beta-Adrenergic blockers, particularly atenolol, are often recommended for the tachycardia and hypertension that accompany hyperthyroidism; however, the effects of monotherapy with atenolol on both systolic blood pressure (SBP) and heart rate (HR) have not been reported." | 7.74 | Efficacy of atenolol as a single antihypertensive agent in hyperthyroid cats. ( Dolson, MK; Henik, RA; Stepien, RL; Wenholz, LJ, 2008) |
| "The authors describe a 62 year-old white male who was diagnosed as autoimmune hyperthyroidism and treated with methimazole and atenolol." | 7.69 | [Acquired sideroblastic anemia and cholestasis in a hyperthyroid patient treated with methimazole and atenolol]. ( Gallo, O; Maccione, E; Mamianetti, A; Mugnolo, R; Muñoz, A; Poggi, U; Ronchetti, RD, 1995) |
| "Serum T4, T3, rT3 and T3 resin uptake (T3 RU) were measured before and after 7 days of treatment with either propranolol, alprenolol, sotalol, atenolol or metoprolol in hyperthyroid patients." | 7.66 | Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. ( Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L, 1983) |
| "The kinetic profiles of oral methimazole 40 mg, propranolol 80 mg, metoprolol 100 mg and atenolol 100 mg were compared in hyperthyroid patients both during the hyper- and euthyroid states." | 7.66 | Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. ( Hallengren, B; Karlberg, BE; Melander, A; Nilsson, OR; Tegler, L; Wåhlin-Boll, E, 1982) |
| "The effect of the beta-1-adrenoceptor blocking agent, atenolol, on serum levels of thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) was studied in twelve hyperthyroid patients." | 7.66 | The effect of atenolol on serum thyroid hormones in hyperthyroid patients. ( Bewsher, PD; How, J; Khir, AS, 1980) |
| "The pharmacokinetics of atenolol and the effect of the drug on the clinical and laboratory features of hyperthyroidism were studied in 23 patients with hyperthyroidism." | 5.06 | Pharmacokinetics and clinical effects of atenolol in therapy of hyperthyroidism. ( Geffner, DL; Hershman, JM; Sladek, J, 1990) |
| "Treatment for one month with propranolol or atenolol, a selective beta-1-adrenoceptor blocking agent, was evaluated in 20 hyperthyroid patients." | 5.04 | Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism. ( Almqvist, S; Kågedal, B; Karlberg, BE; Nilsson, OR; Tegler, L, 1979) |
| "beta-Adrenergic blockers, particularly atenolol, are often recommended for the tachycardia and hypertension that accompany hyperthyroidism; however, the effects of monotherapy with atenolol on both systolic blood pressure (SBP) and heart rate (HR) have not been reported." | 3.74 | Efficacy of atenolol as a single antihypertensive agent in hyperthyroid cats. ( Dolson, MK; Henik, RA; Stepien, RL; Wenholz, LJ, 2008) |
| " In order to estimate the degree of autonomic activation in hyperthyroidism, specific blockers were administered intravenously: atropine (0." | 3.70 | Contribution of the autonomic nervous system to blood pressure and heart rate variability changes in early experimental hyperthyroidism. ( Elghozi, JL; Laude, D; Ponchon, P; Safa-Tisseront, V, 1998) |
| " Atenolol neither modified HR nor BP variability in rats with hyperthyroidism." | 3.70 | Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism. ( Elghozi, JL; Laude, D; Ponchon, P; Safa-Tisseront, V, 1998) |
| "beta-Adrenoceptor antagonists such as propranolol and atenolol ameliorate the symptoms of human hyperthyroidism." | 3.69 | Beta-adrenoceptor antagonism and the hyperthyroid rat heart. ( Amos, G; Brown, L; Kerr, D; Sernia, C, 1994) |
| "The authors describe a 62 year-old white male who was diagnosed as autoimmune hyperthyroidism and treated with methimazole and atenolol." | 3.69 | [Acquired sideroblastic anemia and cholestasis in a hyperthyroid patient treated with methimazole and atenolol]. ( Gallo, O; Maccione, E; Mamianetti, A; Mugnolo, R; Muñoz, A; Poggi, U; Ronchetti, RD, 1995) |
| "To determine whether beta blockade protects against the acceleration of lipid peroxidation in hyperthyroid rat soleus (slow-oxidative) muscle, in vivo chronic (3 weeks) effects of 3 beta blockers with different ancillary properties on mitochondrial oxidative enzymes, antioxidant enzymes, and thiobarbituric acid-reactive substances were investigated." | 3.68 | Differential effects of 3 beta blockers on lipid peroxidation in hyperthyroid muscle. ( Asayama, K; Dobashi, K; Hayashibe, H; Kato, K, 1990) |
| "Serum T4, T3, rT3 and T3 resin uptake (T3 RU) were measured before and after 7 days of treatment with either propranolol, alprenolol, sotalol, atenolol or metoprolol in hyperthyroid patients." | 3.66 | Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. ( Christensen, LK; Hansen, JM; Perrild, H; Skovsted, L, 1983) |
| "The effect of the beta-1-adrenoceptor blocking agent, atenolol, on serum levels of thyroxine (T4), triiodothyronine (T3) and reverse triiodothyronine (rT3) was studied in twelve hyperthyroid patients." | 3.66 | The effect of atenolol on serum thyroid hormones in hyperthyroid patients. ( Bewsher, PD; How, J; Khir, AS, 1980) |
| "Lycopus extract was tested in thyroxine treated hyperthyroid rats (0." | 1.33 | Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats. ( Baumgartner, A; Biller, A; Hegger, M; Korte, B; Vonhoff, C; Winterhoff, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, SK | 1 |
| Sheffield, JS | 1 |
| Roberts, SW | 1 |
| Selen, DJ | 1 |
| Gilbert, MP | 1 |
| Henik, RA | 1 |
| Stepien, RL | 1 |
| Wenholz, LJ | 1 |
| Dolson, MK | 1 |
| Masannat, Y | 1 |
| Gandhy, R | 1 |
| Olajide, O | 1 |
| Kheetan, R | 1 |
| Yaqub, A | 1 |
| Shikara, MM | 1 |
| Polena, S | 1 |
| Solinas, A | 1 |
| Sanghvi, K | 1 |
| Gintautas, J | 1 |
| Vonhoff, C | 1 |
| Baumgartner, A | 1 |
| Hegger, M | 1 |
| Korte, B | 1 |
| Biller, A | 1 |
| Winterhoff, H | 1 |
| Henderson, A | 1 |
| Sheridan, D | 1 |
| Ross, J | 1 |
| Lewis, M | 1 |
| Perrild, H | 1 |
| Hansen, JM | 1 |
| Skovsted, L | 1 |
| Christensen, LK | 1 |
| Hayes, JR | 1 |
| Ritchie, CM | 1 |
| Nilsson, OR | 3 |
| Andersson, RG | 1 |
| Karlberg, BE | 3 |
| Hallengren, B | 1 |
| Melander, A | 1 |
| Tegler, L | 2 |
| Wåhlin-Boll, E | 1 |
| How, J | 1 |
| Khir, AS | 1 |
| Bewsher, PD | 1 |
| Amos, G | 1 |
| Kerr, D | 1 |
| Sernia, C | 1 |
| Brown, L | 1 |
| Mamianetti, A | 1 |
| Muñoz, A | 1 |
| Ronchetti, RD | 1 |
| Maccione, E | 1 |
| Poggi, U | 1 |
| Mugnolo, R | 1 |
| Gallo, O | 1 |
| Safa-Tisseront, V | 3 |
| Ponchon, P | 3 |
| Laude, D | 2 |
| Elghozi, JL | 3 |
| Blanc, J | 1 |
| Gandolfini, MP | 1 |
| Lefrançois, AM | 1 |
| Pannier-Moreau, I | 1 |
| Guiomard, A | 1 |
| McDevitt, DG | 1 |
| Nelson, JK | 1 |
| Kågedal, B | 1 |
| Almqvist, S | 1 |
| Valensi, P | 1 |
| Simon, A | 1 |
| Pithois-Merli, I | 1 |
| Levenson, J | 1 |
| Asayama, K | 1 |
| Hayashibe, H | 1 |
| Dobashi, K | 1 |
| Kato, K | 1 |
| Geffner, DL | 1 |
| Sladek, J | 1 |
| Hershman, JM | 1 |
4 trials available for atenolol and Hyperthyroid
| Article | Year |
|---|---|
Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Fe | 2003 |
Comparative trial of atenolol and propranolol in hyperthyroidism.
Topics: Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hyperthyroidism | 1978 |
Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.
Topics: Adolescent; Adult; Atenolol; Drug Evaluation; Female; Humans; Hyperthyroidism; Male; Middle Aged; Pr | 1979 |
Pharmacokinetics and clinical effects of atenolol in therapy of hyperthyroidism.
Topics: Administration, Oral; Adult; Atenolol; Drug Administration Schedule; Euthyroid Sick Syndromes; Femal | 1990 |
20 other studies available for atenolol and Hyperthyroid
| Article | Year |
|---|---|
Thionamide-induced neutropenia and ecthyma in a pregnant patient with hyperthyroidism.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antithyroid Agents; Atenolol; Drug Eruptions; Ecthyma | 2013 |
Nausea/vomiting · tachycardia · unintentional weight loss · Dx?
Topics: Adult; Antithyroid Agents; Atenolol; Female; Humans; Hyperthyroidism; Methimazole; Nausea; Pulmonary | 2017 |
Efficacy of atenolol as a single antihypertensive agent in hyperthyroid cats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cat Diseases; Cats; Female; Heart Rate; | 2008 |
Chorea associated with thyrotoxicosis due to toxic multinodular goiter.
Topics: Antithyroid Agents; Atenolol; Chorea; Dibenzothiazepines; Female; Goiter, Nodular; Humans; Hyperthyr | 2011 |
Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Body Temperature; Body Weight; Eatin | 2006 |
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroi | 1981 |
Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Humans; Hyperthyroidism; Metoprolol; | 1983 |
Beta-blockers in thyrotoxicosis.
Topics: Antithyroid Agents; Atenolol; Humans; Hyperthyroidism; Metabolic Clearance Rate; Practolol; Propanol | 1980 |
Hypercalcaemia due to thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Atenolol; Humans; Hypercalcemia; Hyperthyroidism; M | 1983 |
Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
Topics: Adult; Aged; Atenolol; Cyclic AMP; Female; Humans; Hyperthyroidism; Male; Middle Aged; Posture; Prop | 1980 |
Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Topics: Administration, Oral; Atenolol; Female; Humans; Hyperthyroidism; Kinetics; Male; Metabolic Clearance | 1982 |
The effect of atenolol on serum thyroid hormones in hyperthyroid patients.
Topics: Adult; Atenolol; Female; Humans; Hyperthyroidism; Male; Middle Aged; Propanolamines; Thyroxine; Trii | 1980 |
Beta-adrenoceptor antagonism and the hyperthyroid rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Hyperthyroidism; In Vitro Techniques; Ma | 1994 |
[Acquired sideroblastic anemia and cholestasis in a hyperthyroid patient treated with methimazole and atenolol].
Topics: Anemia, Sideroblastic; Atenolol; Cholestasis, Intrahepatic; Humans; Hyperthyroidism; Liver Function | 1995 |
Contribution of the autonomic nervous system to blood pressure and heart rate variability changes in early experimental hyperthyroidism.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Atropine; Autonomic Ne | 1998 |
[Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism].
Topics: Animals; Atenolol; Atropine; Autonomic Nervous System; Blood Pressure; Heart; Heart Rate; Hyperthyro | 1998 |
Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism.
Topics: Animals; Atenolol; Atropine; Autonomic Nervous System; Blood Pressure; Cardiomegaly; Disease Models, | 1998 |
[Reversible left intraventricular obstruction after treatment of pheochromocytoma and hyperthyroidism].
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Atenolol; Combined | 1998 |
Non-beta-adrenergic-mediated peripheral circulatory hyperkinesia in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Flow Velocity; Blood Pressure; Brachial Artery; Extremi | 1992 |
Differential effects of 3 beta blockers on lipid peroxidation in hyperthyroid muscle.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carteolol; Hyperthyroidism; Lipid Perox | 1990 |